Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-months Prospective, Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockersfor Benign Prostatic Hyperplasia

NCT07144709 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT07144709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07144709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-months Prospective, Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockersfor Benign Prostatic Hyperplasia
Lead sponsor
Pierre Fabre Medicament
Phase
Observational
Overall status
Completed
Start date
June 22, 2022
Completion date
July 29, 2024
Enrollment
288 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia